University of Florida

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).

1,106 total trials 170 currently recruiting 754 completed early-phase tilt top decile by trial count

University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.

University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.

Top-decile sponsor footprint

University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 60/100

754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,106 total, page 1 of 23

RECRUITING Phase 2

Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)

NCT06868238

RECRUITING

Clinical Safety Guidelines for Managing Distal Shoe Complications

NCT07410442

RECRUITING NA

Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions.

NCT07351110

RECRUITING NA

Cross-System Effects of Acute Intermittent Hypercapnia-Based Interventions in PD

NCT07674264

RECRUITING NA

Interposed Nucleus aDBS for Ataxia

NCT07325487

RECRUITING NA

Bio Leg: Advancing Mobility (BAM)

NCT07613502

RECRUITING NA

Telehealth-Adapted Compensatory Training and Intervention for Cognition

NCT07366346

RECRUITING NA

Yellow Potatoes and Carotenoids

NCT07606001

RECRUITING NA

Digitally Delivered Child Obesity Prevention for Parents in Home Visiting Programs

NCT07230808

RECRUITING NA

uSafeUS+ App Pilot Testing

NCT07557745

RECRUITING NA

Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting

NCT07410598

RECRUITING Phase 1

RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)

NCT07492316

RECRUITING NA

Supraspinatus Tendon Acute Effects After Two Exercise Exposures: a Crossover Randomized Trial.

NCT07489937

RECRUITING Phase 2

Treating Spinal Cord Injury With Early Normobaric Hyperoxia

NCT07465302

RECRUITING NA

Cranberry Polyphenols and Stress Resilience During Multitasking in Healthy Adults

NCT07453537

RECRUITING NA

Dental-Child Interaction Training

NCT06138405

RECRUITING NA

Rehab and Mechanical Ventilation

NCT07427121

RECRUITING NA

Improving Speech in Noise Using Noninvasive Stimulation

NCT07176936

RECRUITING NA

Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study

NCT07376772

RECRUITING Phase 1

Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events

NCT06863480

RECRUITING NA

Adding Polyphenol-rich Pulses to Daily Diet Improves Skin Health by Reshaping the Skin Microbiome

NCT06538415

RECRUITING Phase 2

A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia

NCT07107334

RECRUITING Phase 2

Zinc as an Adjunctive Therapy for Cervical Dystonia

NCT07140874

RECRUITING Phase 4

The Bridging Antiplatelet Therapy With Cangrelor 2 Study

NCT07225842

RECRUITING NA

Magnetoencephalography (MEG) Pilot Study

NCT07446192

RECRUITING NA

Prefrontal Theta Burst Stimulation to Improve Cognitive Impairment After ICU Delirium

NCT07452939

RECRUITING Phase 1

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

NCT06625190

RECRUITING

Colorectal Cancer Prevention Research Study: Eat Right, Screen Right

NCT07393906

RECRUITING Phase 1

Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization

NCT05264974

RECRUITING

ECHO Diabetes FQHC

NCT07417865

RECRUITING NA

An Emergency Department (ED) Provider Centered Intervention for Non-Traumatic Dental Condition Management (NTDC)

NCT06330207

RECRUITING NA

Electrophysiology-based DBS Programming for PD

NCT07348705

RECRUITING Phase 1

Living Independence Through Functional Training

NCT07125378

RECRUITING

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

NCT07214584

RECRUITING NA

The Florida ASCENT Study

NCT07042243

RECRUITING Phase 1

Linaclotide for Colonoscopy Bowel Prep

NCT06692673

RECRUITING NA

Improving Speech in Noise Perception for Individuals With Age-related Hearing Loss

NCT07192757

RECRUITING NA

Compassion Strikes Back

NCT06988995

RECRUITING Phase 4

Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure

NCT06979726

RECRUITING NA

Hypoxia Pathways for Early Recovery After Spinal Cord Injury

NCT07002437

RECRUITING Phase 2

Precision Administration of Anti-thymocyte Globulin With or Without Verapamil

NCT06455319

RECRUITING NA

WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)

NCT06861790

RECRUITING

Does Undergoing a Prehabilitation Protocol Aimed at Optimizing Scapulothoracic Mobility and Strengthening Improve Internal Rotation After Reverse Shoulder Arthroplasty?

NCT07145957

RECRUITING NA

Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions

NCT06903468

RECRUITING Phase 4

Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)

NCT07025148

RECRUITING NA

Temperature Rise Caused by Short or Long-wavelengths

NCT06418958

RECRUITING NA

Walking Sensation Study

NCT06975423

RECRUITING NA

Project HOPEFUL: A PN-RCT With Implementation Science

NCT07475039

RECRUITING NA

RESPARK - Brain Q for Chronic Stroke

NCT07095920

RECRUITING

Parathyroidectomy and Mobility Study

NCT07103876

Page 1 of 23 Next →

Phase Distribution

PhaseTrial count
Phase 1 123
Phase 2 109
Phase 3 13
Phase 4 90

What is open in the University of Florida pipeline

170 recruiting of 1,106 indexed (15% open); 754 completed (68%).

Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).

Top condition: Coronary Artery Disease (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Florida: open-pipeline peers nationwide

Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 8%10%12%14%16%18%20% Total trials Recruiting share University of FloridaUniversity of North Carolina, Chapel HillWake Forest University Health SciencesUniversity of Alabama at BirminghamNYU Langone HealthArrowhead Regional Medical CenterAurinia PharmaceuticalsBronx VA Medical CenterCandel Therapeutics
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,106 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this University of Florida page

1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.

  • 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Florida pipeline card: 1,106 registered trials from official public datasets.Report a data error.